DOVE – Stop Cholera
Cholera is a growing threat, especially for those most vulnerable. Each year about 2.5 million people suffer from cholera, and 100,000 to 200,000 die from the disease. Oral cholera vaccine (OCV) can prevent illness and save lives if used efficiently and appropriately.
The Delivering Oral Cholera Vaccine Effectively (DOVE) project provides tools and resources to countries and agencies who are dealing with the threat of cholera in order to assist them in making evidence-based decisions regarding when and how to use OCV. The project goal is increased and appropriate use of OCV to reduce cholera cases and prevent deaths. The project website, www.StopCholera.org, advocates for cholera programs to Stop Cholera: work together, stop transmission and end cholera deaths.
The project has four main objectives:
1. Provide research and evaluation support for current and future OCV projects
2. Develop a rapid and practical OCV toolkit to guide decisions on use of OCV
3. Characterize the epidemiology of cholera in specific settings using simplified epidemiological and lab methods to guide the use of OCV in Africa
4. Disseminate the results of OCV programs and opportunities
Specifically, the project provides research and evaluation support for OCV campaigns, conducts cholera surveillance, reviews cholera epidemiology, provides vaccination technical assistance, leads vaccine research studies, and generates resources to guide the use of OCV globally. The project currently has activities in Cameroon, Uganda, Malawi, South Sudan, Nepal and the Philippines.
The Center for Communication Programs (CCP) supports the knowledge management, advocacy, and dissemination activities of the DOVE project through www.StopCholera.org, including the Stop Cholera Toolkit which provides resources for decision-makers to help decide if, when, where, and how to use oral cholera vaccine to reduce cholera mortality, prevent cases, and halt outbreaks.
The Delivering Oral Cholera Vaccine Effectively (DOVE) project is a sx-year project (2012-2018) led by the Department of International Health at JHSPH and funded by the Bill & Melinda Gates Foundation.